Clinical Trials

108 enrolled

Phase 1 Active not recruiting

Nasopharyngeal Carcinoma

NCT02065362 2026-01-29

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

14 enrolled

Nasopharyngeal Carcinoma, Camurati-Engelmann Syndrome

NCT05340270 2025-12-11

NeoTurbo

150 enrolled

Nasopharyngeal Carcinoma

NCT07248670 2025-11-25

Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC

252 enrolled

Phase NA Active not recruiting

Nasopharyngeal Carcinoma

NCT07248696 2025-11-25

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

32 enrolled

Nasopharyngeal Carcinoma

NCT07088861 2025-11-18

Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China

1,401 enrolled

Nasopharyngeal Carcinoma

NCT04925544 2025-10-21

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

13 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT04384627 2025-09-04

NPC-GTV

445 enrolled

Nasopharyngeal Carcinoma

NCT04907370 2025-07-16

DIAMOND

532 enrolled

Nasopharyngeal Carcinoma

NCT07011329 2025-06-11

NPC

60 enrolled

Nasopharyngeal Carcinoma, Niemann-Pick Disease, Type A, Cognitive Dysfunction

NCT04456322 2025-05-14

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

381 enrolled

Nasopharyngeal Carcinoma

NCT04517214 2025-04-02

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

100 enrolled

Nasopharyngeal Carcinoma

NCT05304468 2025-03-21

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

452 enrolled

Nasopharyngeal Carcinoma

NCT06881225 2025-03-18

Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: An MRI Study

300 enrolled

Nasopharyngeal Carcinoma

NCT04223024 2025-03-05

Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma

246 enrolled

Nasopharyngeal Carcinoma

NCT05587374 2025-01-23

GEMSTONE

490 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT06787456 2025-01-22

"Xijiang Project" Screening Cohort for NPC

1,000,000 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT03840421 2025-01-13

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

468 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT06762470 2025-01-09

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

325 enrolled

Nasopharyngeal Carcinoma

NCT05869227 2024-12-30

Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

166 enrolled

Nasopharyngeal Carcinoma

NCT02460887 2024-12-03

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

236 enrolled

Nasopharyngeal Carcinoma

NCT06612697 2024-09-25

Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone

262 enrolled

Nasopharyngeal Carcinoma, Neoplasms

NCT06523933 2024-07-26

Distribution of Bacteria in OME After Radiotherapy For NPC.

234 enrolled

Nasopharyngeal Carcinoma, Otitis Media with Effusion

NCT05193617 2024-07-23

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

104 enrolled

Nasopharyngeal Carcinoma

NCT03306121 2023-05-22

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

322 enrolled

Nasopharyngeal Carcinoma

NCT03047265 2017-02-10

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

164 enrolled